Illumina, Inc.

NasdaqGS:ILMN 株式レポート

時価総額：US$17.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Illumina 過去の業績

過去 基準チェック /06

Illuminaの収益は年間平均-60%の割合で減少していますが、 Life Sciences業界の収益は年間 増加しています。収益は年間16.4% 7.7%割合で 増加しています。

主要情報

-60.0%

収益成長率

-59.8%

EPS成長率

Life Sciences 業界の成長21.5%
収益成長率7.7%
株主資本利益率-22.5%
ネット・マージン-28.7%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$106?

May 26
Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$106?

Illumina: Expect A Slow Rebound

May 07

Calculating The Fair Value Of Illumina, Inc. (NASDAQ:ILMN)

Apr 26
Calculating The Fair Value Of Illumina, Inc. (NASDAQ:ILMN)

Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)

Mar 20
Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)

Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition

Feb 23

Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Jan 26
Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024

Jan 19

Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%

Dec 21
Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%

Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?

Dec 03
Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?

Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Oct 24
Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?

Oct 03
Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?

At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?

Aug 22
At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?

The Big Trends: New Frontiers in Healthcare

Jul 13
The Big Trends: New Frontiers in Healthcare

Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)

Jul 03
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt

Jun 13
Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt

Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?

Apr 12
Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?

Is Illumina (NASDAQ:ILMN) Using Too Much Debt?

Mar 14
Is Illumina (NASDAQ:ILMN) Using Too Much Debt?

Are Investors Undervaluing Illumina, Inc. (NASDAQ:ILMN) By 38%?

Dec 30
Are Investors Undervaluing Illumina, Inc. (NASDAQ:ILMN) By 38%?

Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$221?

Dec 02
Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$221?

These 4 Measures Indicate That Illumina (NASDAQ:ILMN) Is Using Debt Reasonably Well

Oct 27
These 4 Measures Indicate That Illumina (NASDAQ:ILMN) Is Using Debt Reasonably Well

Illumina, GenoScreen collaborate on genomic testing for drug-resistant TB

Oct 18

Illumina in research collaboration with AstraZeneca on drug target discovery

Oct 11

Illumina Engages Obama To Push Its Customers' Reimbursement Agenda

Sep 29

Illumina to appeal EU decision to block GRAIL acquisition

Sep 06

Illumina Needs Grail, But May Lose It

Aug 30

Illumina added to positive catalyst watch at Citi despite Q2 miss

Aug 22

Illumina up 9% following drop after Q2 earnings

Aug 15

収支内訳

Illumina の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

NasdaqGS:ILMN 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 244,493-1,2901,6461,204
31 Dec 234,504-1,1611,6371,207
01 Oct 234,465-1,1251,6101,248
02 Jul 234,461-4,1861,6361,272
02 Apr 234,448-4,4871,6361,227
01 Jan 234,584-4,4041,6141,209
02 Oct 224,700-4,1531,6821,242
03 Jul 224,693-201,5101,187
03 Apr 224,6567011,5501,061
02 Jan 224,5267621,744914
03 Oct 214,2809071,351794
04 Jul 213,9667691,350696
04 Apr 213,4736301,114650
03 Jan 213,2396561,014609
27 Sep 203,238638813572
28 Jun 203,351693811551
29 Mar 203,556942835562
29 Dec 193,5431,002907575
29 Sep 193,458973874607
30 Jun 193,405938881615
31 Mar 193,397851877600
30 Dec 183,333826849568
30 Sep 183,243684798538
01 Jul 183,103648768513
01 Apr 182,936567732492
31 Dec 172,752725720500
01 Oct 172,594775692488
02 Jul 172,487741664480
02 Apr 172,424730652474
01 Jan 172,398454630458
02 Oct 162,371440624450
03 Jul 162,314430621423
03 Apr 162,253415597395
03 Jan 162,220462561362
27 Sep 152,141510533348
28 Jun 152,071486516334
29 Mar 151,979430506321
28 Dec 141,861353499306
28 Sep 141,736281478294
29 Jun 141,612219453279
30 Mar 141,511208430264
29 Dec 131,421125423249
29 Sep 131,343117378212
30 Jun 131,272115356195

質の高い収益: ILMNは現在利益が出ていません。

利益率の向上: ILMNは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: ILMNは利益が出ておらず、過去 5 年間で損失は年間60%の割合で増加しています。

成長の加速: ILMNの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: ILMNは利益が出ていないため、過去 1 年間の収益成長をLife Sciences業界 ( -8.1% ) と比較することは困難です。

株主資本利益率

高いROE: ILMNは現在利益が出ていないため、自己資本利益率 ( -22.5% ) はマイナスです。

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

7D

1Y

7D

1Y

7D

1Y